InvestorsHub Logo

williamssc

06/03/17 8:40 PM

#184059 RE: runninggirl2016 #184058

Exactly right. I believe a certain big pharma is involved hence the specific design. The end goal here is to provide the critical data necessary to forge a partnership with a large pharmaceutical company interested in co-developing.

petemantx

06/03/17 9:55 PM

#184064 RE: runninggirl2016 #184058

When is the Kevetrin trial expected to wrap up?

ericseb2003

06/04/17 5:12 AM

#184069 RE: runninggirl2016 #184058

Where is the public record of this oft-repeated assertion that this latest K trial was insisted on by a BP and relatedly, where was it that the company acknowledged they are doing this trial with the exclusuve intent of partnering if/when the POC results meet this specific BP's expectations?

I must have missed all the talk the company has given on this topic, and look forward in advance to clear and unequivocal answers.

frrol

06/04/17 10:29 AM

#184079 RE: runninggirl2016 #184058

More accurately, BP told them what they'd like to see. (And it is no surprise at all. I've been looking for deeper K MOA research myself since 2014, and I'm just some retail investor in the company.) The point was it is being done to get an immediately subsequent deal.